Le Moniteur Hospitalier : Compléments
Bibliographie dossier (n°223): Psychoses pharmaco-induites
Quelques repères bibliographiques...
Ben Amar M., Potvin S. (2007)
Cannabis and psychosis: what is the link ?
J. Psychoactive Drugs, 39(2), pp.131-142.
Coulston C.M., Perdices M., Tennant C.C. (2007)
The neuropsychological correlates of cannabis use in schizophrenia : lifetime abuse / dependance, frequency of use, and recency of use.
Schizophr. Res., 96(1-3), pp.169-184.
Ellgren M., Artmann A., Tkalych O., Gupta A., Hansen H.S., Hansen S.H., Devi L.A., Hurd Y.L. (2008)
Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects.
Eur. Neuropsychopharmacol., 18(11), pp.826-834.
Freedman et al. (2008).
Cannabis, inhibitory neurons, and the progressive course of schizophrenia.
Am. J. Psychiatry, 165, pp.416-419.
Gilbert G.L., Kim H.J., Waataja J.J., Thayer S.A. (2007)
Delta-9-tetrahydrocannabinol protects hippocampal neurons from excitotoxicity.
Brain Res., 1128(1), pp.61-69.
Gonzalez-Pinto A, Vega P, Ibanez B, Mosquera F, Barbeito S, Gutierrez M, et al. (2008)
Impact of cannabis and other drugs on age at onset of psychosis.
J. Clin. Psychiatry. 69(8), pp.1210-1216.
Hall W., Degenhardt L. (2008)
Cannabis use and the risk of developing a psychotic disorder.
World Psychiatry, 7(2), pp.68-71.
Keshavan M.S., Tandon R., Boutros N.N., Nasrallah H.A. (2008)
Schizophrenia, "just the facts": what we know in 2008 (neurobiology).
Schiz. Res., 106, pp.89-107.
Laqueille X., Launay C., Kanit M. (2008)
Les troubles psychiatriques et somatiques induits par le cannabis.
Ann. Pharm. Fr., 66(4), pp.245-254.
Miettunen J., Törmänen S., Murray G.K. et al. (2008)
Association of cannabis use with prodromal symptoms of psychosis in adolescence.
Br. Journal of Psychiatry, 192 pp.470-471.
Moore T.H., Zammit S, Lingford-Hughes A, Barnes T.R., Jones P.B., Burke M, Lewis G. (2007)
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Lancet, 28;370(9584), pp.319-328
Palmer R.H., Young S.E., Hopfer C.J. et al. (2009)
Developmental epidemiology of drug use and abuse in adolescence and young adulthood: evidence of generalized risk.
Drug Alcohol Depend., 26 (publication électronique).
Rathbone J., Variend H., Mehta H. and the Cochrane Schizophrenia Group (2009)
Cannabis and schizophrenia (review).
Yücel M., Lubman D.I., Solowii N., Brewer W.J. (2007)
Understanding drug addiction: a neuropsychological perspectives.
Aus. N.Z. Psychiatry, 41(12), pp.957-968.
Yücel M., Solowii N., Respondek C., Whittle S., Fornito A., Pantelis C., Lubman D.I. (2008)
Regional abnormalities associated with long-term heavy cannabis use.
Arch. Gen. Psychiatry, 65(6), pp.694-701.
Zammit S., Moore T.H., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., Lewis G. (2008)
Effects of cannabis use on outcomes of psychotic disorders: systematic review.
Br. J. Psychiatry, 193(5), pp.357-363.
Nouveautés
ORL - Oto-rhino-laryngologieLe pharmacien d’officine est un acteur de santé de premier recours. Il est consulté pour toutes sortes de maux et doit pouvoir conseiller des traitements homéopathiques.
28.02 € TTC
En savoir plus
(Publicité)
forums
Exprimez-vous et échangez avec vos confrères sur les forums du Moniteur ou de Porphyre
 |
Nous adhérons aux principes de la charte HONcode. Vérifiez ici. |
 |
 La fréquentation de ce site est certifiée par l'OJD |